List of Diagnostics Companies in Texas - 35
Search through the full list with powerful filtering options
Want this in Excel? Get Quote NowCompany | About |
---|---|
Accel Diagnostics, LLC Houston, Texas, United States | Accel Diagnostics is medical diagnostic company developing proprietary point-of-care diagnostic assay for the diagnosis, monitoring and management of a wide variety of medical conditions. We are dedicated to making a difference in the quality of life of millions of patients through technology and innovation. AccelDx’s technology enables patients and healthcare providers to perform lab-quality medical diagnostic tests anytime and anywhere. The Company's patented platform technology transforms the patient blood testing paradigm, from lab-centered to near-patient. The technology bringing significant advantages in terms of simplicity, time to result, care delivery, and cost over current standard lab-based diagnostics. During COVID-19 pademic Accel Diagnostics began to operate the ADX Diagnostic Lab to provide high quality COVID testing in Houston, TX. |
Alphadera Labs Houston, Texas, United States | AlphaDERA Labs, LLC. is a full-service medical laboratory providing wellness testing, routine blood chemistry, prescription & illicit drug test including urinary tract testing, respiratory pathogen testing, and COV-19 antigen testing for healthcare facilities, clinics, and PCR Covid-19 testing for patients. |
Aranscia Houston, Texas, United States | Aranscia unlocks the power of precision medicine by serving the needs of clinical professionals directly within the care workflow. |
Astrotech Austin, Texas, United States | Astrotech is an innovative science and technology development and commercialization company. We invent, acquire, and commercialize technological innovations sourced from research institutions, laboratories, and internally to maximize shareholder value. Our current subsidiaries consist of: AgLab (Aglab.com) AgLAB Inc. is an advanced mass spectrometry tech company that focuses on distillation for THC and CBD oils based in Austin, Tx. Our products continually test in-process and provide immediate information that maximizes the potency and ending weight yields of every batch. Yield improvements average 34%. 1stDetect (1stDetect.com) 1st Detect's Tracer 1000 is the most accurate Narcotics and Explosives Trace Detector available. Delivering Advanced Lab-Accurate Mass Spectrometry, our solution is already used in 14 countries worldwide and is known for its simple interface, rapid detection cycle, and near zero false positives. With an unlimited threat library, customers can stay up to date with the latest explosive and narcotic profiles. The Tracer 1000 is reliable, rugged, and provides high specificity, all while ensuring maximum uptime and availability. BreathTech (BreathTech.com) BreathTech Corp. is an advanced mass spectrometry tech company that detects diseases through breath analysis based in Austin, Tx. Our first product, BreathTest-1000™ is the first one-minute test for the detection of lung diseases associated with the COVID-19 infection. The machines are currently utilized by major institutions like NASA, U.S. Army, and airport security for the HHS. Astrotech was founded in 1984 in Delaware as a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology. You can learn more about our history here: https://www.astrotechcorp.com/about Interested in one of our products? Visit the website and contact us and someone will be in touch with you shortly. |
Autonomix Medical 21 waterway avenue, spring, texas, united states | Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum. |
Baylor Genetics Houston, Texas, United States | Baylor Genetics offers a full spectrum of cost-effective, genetics testing and provides clinically relevant solutions. They offer whole exome sequencing, prenatal diagnostics, cytogenetics, molecular diagnostics, oncology, chromosomal microarray analysis, and over 30 enzyme assays. Along with these tests come interpretation services. |
bioAffinity Technologies 22211 W Interstate 10, San Antonio, Texas 78257, US | Addressing a critical need to find cancer early and treat cancer specifically, bioAffinity Technologies, Inc. develops tests and therapies to detect and treat cancer at the cellular level. Our first product, CyPath® Flow Cytometry for Lung Cancer (CyPath® Lung), has been licensed by Precision Pathology Services for continued development and commercial sale as a Laboratory Developed Test. CyPath® Lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs. |
BioCentra Round Rock, Texas, United States | We develop novel and sustainable products and technologies in bio-therapeutics, vaccines and personalized diagnostics of cancer and infectious diseases. Most of the company's efforts have been directed toward in-house innovation in drug development and diagnostics; biotechnology consulting to pharmaceutical companies interested in technologies related to biosimilar and biologics development; and specialized contract research services to clinical and academic research institutions in order to design solutions based on novel methods and protocols useful in clinical validation of biopharmaceutical molecules and vaccines. |
C4 Imaging 6575 West Loop South, Bellaire, Texas, USA, 77401 | C4 Imaging develops innovative medical devices that enable clinicians to personalize patient treatment through accurate image-guided procedures. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within an implantable, biocompatible shell. C4 Imaging's first product is the Sirius™ MRI Marker, which will be used to facilitate seed localization during the treatment of prostate cancer. The Sirius™ MRI Marker will allow physicians to accurately locate seeds within the complicated anatomy of the prostate and the surrounding critical structures, utilizing a single post-implant MR imaging procedure. C4 Imaging's goal is to improve quality assurance by allowing post-implant seed localization to be performed with MRI alone, eliminating the need for computed tomography in assessment of prostate brachytherapy. |
Castle Biosciences Friendswood, Texas, United States | Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. The Company’s innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. Castle currently markets six proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, Barrett’s esophagus, mental health and uveal melanoma. DecisionDx®-Melanoma, Castle’s test for invasive cutaneous melanoma, is a proprietary gene expression profile (GEP) test that uses an individual patient’s tumor biology to predict the risk of metastasis or recurrence, as well as the risk of sentinel lymph node positivity, independent of traditional staging factors. DecisionDx®-SCC is the Company’s GEP test that predicts the risk of metastasis in patients with cutaneous squamous cell carcinoma, who have one or more risk factors. MyPath® Melanoma provides a highly accurate, objective result to aid dermatopathologists and dermatologists in characterizing suspicious pigmented lesions. TissueCypher® Barrett’s Esophagus is the world’s first precision medicine test designed to predict future development of esophageal cancer in patients with Barrett’s esophagus. IDgenetix is Castle's pharmacogenomic (PGx) test for depression, anxiety and other mental health conditions designed to analyze a patient’s genetic make-up to guide timely and evidence-based decisions on the optimal drug for each patient. DecisionDx®-UM, the standard of care in uveal melanoma staging, is Castle's GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer. Castle Biosciences is based in Friendswood, TX, (a suburb of Houston) and has laboratory operations in Phoenix, AZ, and Pittsburgh, PA. |
Detekt Biomedical Austin, Texas, United States | Detekt is a life sciences product design and engineering firm. Over the last 15 years, the team has worked alongside both private and public companies to launch products that fulfill each client’s vision and successfully go to market. |
Everlywell Austin, Texas, United States | Everlywell believes that health tests shouldn't be hard to get – or hard to understand. The Everlywell experience is simple. You order one of our kits online, you collect your sample from home and return it via pre-paid mail to one of our fully-certified partner laboratories. A board-certified physician in your state will review and validate your results before you get them. Everlywell provides a complete, easy-to-read results report online in just a few days. Our comprehensive tests measure key biomarkers through samples that are collected in the comfort of your home. Everlywell empowers individuals by providing easy access to health data. We are proud to offer 30+ consumer-initiated, regulatory-compliant tests…without a lab visit. |
Genome Explorations Houston, Texas, United States | A premier research institution providing global genomic profiling and molecular diagnostics services to academic centers, pharmaceutical and biotech industry, oncologists, and pathologists with innovative diagnostic, prognostic, predictive, and personalized testing. Genome Explorations, a Tesis Biosciences company, is a state of the art CLIA certified GLP compliant Lab providing NextGen sequencing, Genotyping, Gene Expression and microRNA profiling services. Our Clients range from Fortune 500 Pharmaceutical and Biotech to Individual Investigators at Academic institutes and are located worldwide. Our experienced scientists work one-on-one with researchers and clinicians to provide a ‘Complete Solution' for all their Research and Clinical needs, from experimental design to in-depth data analysis and advanced bioinformatics. Genome Explorations also offers ‘Complete Solutions' for challenging specimens, such as whole blood and FFPE tissues. |
Healgen Scientific Houston, Texas, United States | Healgen Scientific is a leading global IVD developer and manufacturer focused on delivering life-changing diagnostic products for patients worldwide. For over 17 years, we have strived to provide world-class products and services across multiple healthcare sectors, such as Infectious Diseases, Toxicology, Fertility & Women's Health, Oncology, Cardiovascular, Metabolism, and more. As a highly trusted healthcare partner for over 140 facilities, we develop state-of-the-art devices that exceed industry standards and redefine healthcare, and our portfolio spans multiple testing platforms. |
Helena Laboratories Corporation 1530 Lindbergh Dr, Beaumont, Texas 77707, US | Helena Laboratories is a clinical laboratory instrument and reagent manufacturer. Our clients include major medical centers, small hospitals, large reference laboratories and small private doctor's laboratories. Corporate headquarters, located in Beaumont, Texas (a major port city 80 miles east of Houston) is comprised of over a quarter million square feet of research, manufacturing, inventory, engineering and administrative facilities. Approximately 75 field specialists are located in major cities throughout the United States. Helena has been awarded the U.S. Secretary of Commerce "E" Award for excellence in contribution to the American economy through export operations. With hundreds of laboratory products and more than 40 registered patents, Helena continues to be a market leader in the development of new diagnostic tests. |
Hera Biotech San Antonio, Texas, United States | Hera Biotech is developing and commercializing a non-surgical test for endometriosis diagnosis and staging. |
Ikonopedia Richardson, Texas, United States | Ikonopedia is a next-generation breast radiology reporting and patient tracking system. Our closed-loop system is automated to track and monitor patients to full resolution of all clinical concerns. Clinical reports are clear, consistent, and 100% compliant with the ACR BI-RADS® Atlas 5th Edition. Ikonopedia is MQSA-compliant and offers screening and diagnostic modalities that will improve patient safety and save valuable time for the radiologist and staff. |
Inform Diagnostics - A Fulgent Genetics Company 1111 S. Freeport Pkwy., Coppell, Texas 75019, US | Inform Diagnostics, a Fulgent Genetics Company, is a leading pathology laboratory trusted by clinicians throughout the U.S. We provide timely, accurate and definitive patient diagnoses in the fields of dermatopathology, gastrointestinal pathology, hematopathology, neuropathology, breast pathology, molecular diagnostics (Covid-19 testing), and genitourinary pathology. Working for Inform Diagnostics means you will contribute alongside top multidisciplinary talent in an environment with cutting-edge tools and breakthrough technologies. It is a place where people are passionate in their belief that every patient deserves the right answer. Driven by an unwavering dedication to quality, Inform Diagnostics profoundly impacts patient care, one diagnosis at a time. The company has state-of-the-art laboratories in Boston, Dallas, New York City, and Phoenix. Visit us at informdx.com. |
John Welsh Cardiovascular Diagnostic Laboratory (Baylor College of Medicine) Houston, Texas, United States | Baylor College of Medicine is a health sciences university that creates knowledge and applies science and discoveries to further education, healthcare and community service locally and globally. Located in the Texas Medical Center, Baylor College of Medicine has affiliations with eight teaching hospitals, each known for medical excellence. The college has total research support of over $400 million annually, and more than 90 research and patient-care centers and units. Currently, Baylor College of Medicine trains more than 3,000 medical, graduate, nurse anesthesia, physician assistant, orthotics and prosthetics and genetic counseling students, as well as residents and post-doctoral fellows. |
L7 Informatics 1219 W 6th St, Austin, Texas, US | L7 Informatics provides a unified data and process platform (L7|ESP™) to streamline and optimize manufacturing, laboratory, and business processes across life sciences and healthcare value chains. The L7 Informatics' Unified Platform L7|ESP, with its Workflow Orchestration and Data Contextualization, meets the organizational needs of any life science organization digitalizing their data and laboratory processes, of which the result is maximized total ROI (return of investment), increased utilization and efficiency, and decreased overall cost. L7|ESP captures routine information in smaller labs, while also driving sophisticated wet and dry laboratory processes across an enterprise organization which requires data and analytics strategies that support LotF (lab of the future). The L7|ESP platform integrates all common data information management systems, including LIMS, Notebooks, and MES, but also other resources such as instrument connectors, sample registration, location, receipt accessioning, logistics, scheduling, inventory, environment monitoring, stability testing, custody of chain, and data analytics. L7|ESP is built by scientists for the life sciences community - relentlessly focusing on serving our customers in research, pharma, and diagnostics with the overall goal of better patient outcome. L7 Informatics is supporting customers around the globe that are tackling some of the most challenging and exciting opportunities in healthcare. |
MedCognetics Dallas, Texas, United States | MedCognetics provides an advanced AI software platform which integrates into the radiology workflow. The AI platform is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating more predictable medical outcomes and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com. |
Medical Device Usability Chicago, Texas, United States | Emergo provides quality and regulatory compliance consulting to medical device and IVD companies. We assist with medical device registration/approval, regulatory strategy, ISO 13485 and QMS compliance, local in-country representation and post market surveillance in 20+ markets worldwide. Offices in North America, South America, Europe, Asia, Australia and the Middle East. |
MicroGen Diagnostics Lubbock, Texas, United States | MicroGenDX provides qPCR+NGS sequencing for the detection of infectious diseases. The American Medical Association (AMA) and Medicare have issued a billing code to MicroGenDX to provide this testing service, recognizing this technology as medically necessary. MicroGenDX is trusted by over 39,000 physicians worldwide and has helped over 900,000 patients with diagnostic testing for their chronic and life-threatening infections. MicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory. Tens of thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX's work. MicroGenDX's NGS technology offers several advantages over traditional culture-based methods for identifying microorganisms. It can detect a wider range of microorganisms, including those that are difficult to culture or grow in a laboratory. It also provides more accurate and comprehensive results, as it can detect multiple microorganisms in a single sample and identify them at the species or strain level. Additionally, NGS technology is faster than traditional methods, allowing for quicker diagnosis and treatment decisions. MicroGenDX's testing services are used in a variety of settings, including hospitals, long-term care facilities, dental offices, and veterinary clinics. Their technology has been applied to a wide range of clinical conditions, including chronic wounds, orthopedic infections, respiratory infections, and urinary tract infections, among others. |
Nanoscope Technologies 1312 brown trl, bedford, texas, united states | Nanoscope Technologies was founded in 2009 with an objective to develop new methods and devices for scientific, industrial and biomedical applications. Nanoscope has developed a range of biomedical technologies which include diagnostics and therapeutic devices and molecules. These have already generated interest from several clinicians, industries and leaders. We strive to translate the technology to market and bedside. |
Nuclein 7301 north fm 620, austin, texas, united states | Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's mission is to create a hand-held, disposable, all-in-one, self-test for infectious disease testing, which delivers battery-powered, sample-to-answer results within one hour, without the need to mail in a sample. The company is headquartered in Austin, Texas. |
NuProbe Houston, Texas, United States | The NuProbe team has pioneered the development of a unique and novel PCR-based enrichment method called Blocker Displacement Amplification (BDA). The BDA technology enables the selective amplification of low abundant sequence variants (SNV and indels) in a background of wildtype DNA. |
Octagos Health 13325 Hargrave Road, Suite 281, Houston | Octagos Health is a dynamic and rapidly growing healthcare technology company dedicated to improving patient outcomes through AI-driven solutions. Octagos provides a cloud-based platform that aggregates remote and in-person device interrogations for all cardiac rhythm management (CRM) manufacturers, wearables (Holter, MCT, etc.) and remote physiologic monitoring (RPM). |
Pattern BioSciences Austin, Texas, United States | Tackling a global health threat like antimicrobial resistance is not for the faint of heart, but the experienced and innovative team at Pattern Bioscience is on a mission to do it. Each year, drug-resistant bacterial infections claim more than a million lives globally and cost our healthcare system billions of dollars. Traditional diagnostic methods for bacterial infections remain rooted in slow, cumbersome, decades-old technology that contributes to sub-optimal treatment and the misuse of broad-spectrum antibiotics. The Pattern system is different. We’re developing the world’s only culture-free, rapid diagnostic technology that will reduce the time needed for pathogen identification (ID) and antibiotic susceptibility test (AST) results from days to hours. Our technology combines single-cell analysis of microorganisms with machine learning tools to deliver fast, clinically actionable information. The result? Patients get the right treatment faster, to save lives, prevent side effects and reduce healthcare costs. |
RadioMedix Houston, Texas, United States | RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models. |
Seno Medical 8023 Vantage Dr, San Antonio, Texas 78230, US | Seno Medical is leading commercialization efforts in opto-acoustic imaging of breast cancer. Seno's opto-acoustic technology combines both laser optics and conventional ultrasound technology to provide fused functional and anatomical imaging in real time. The result is an imaging device that delivers additional functional information regarding breast masses and increases confidence in making a breast biopsy decision. For more information or to answer any questions call 210-615-6501 or email digitalmarketing@senomedical.com. Seno's Imagio® Breast Imaging System (9005) received the CE Mark (April 2014) and has completed a post-market surveillance and clinical follow-up study in Europe. The newest version (9100) is approved by the FDA for commercial distribution in the U.S. |
Spectral AI 2515 Mckinney Ave, Suite 1000, Dallas, TX 75201, US | Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by "Seeing the Unknown®" with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of changing the current standard of care in the future, DeepView® is expected to provide faster and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. |
Starling Medical Houston, Texas, United States | At Starling is building a first-of-its-kind at home urology remote patient monitoring platform that seamlessly integrates into anyone's bathroom routine. By monitoring changes in urine over time, we aim to bring the hospitalization reduction benefits of remote monitoring to a new range of chronic conditions such as recurrent UTIs, BPH, and chronic kidney disease. |
VERAVAS, Inc. 111 Congress Avenue, Suite 500, Austin, TX 78701, US | Veravas is transforming laboratory diagnostics through its proprietary VeraBIND™ technology that makes early disease detection possible in any sample type. Through VeraBIND, Veravas is bringing greater patient access to high-value diagnostic tests for neurodegenerative disorders that have not been previously possible. To learn more about our technologies and clinical applications, visit veravas.com. |
Vigilant Biosciences, Inc. 1008 Ranch Road 620, Suite 204, Lakeway , TX 78734, US | Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilant™ OraFusion System aids clinicians with identifying patients at risk for oral cancers. It is simple, accurate and cost-effective, empowering healthcare practitioners to improve lives through earlier intervention. The BeVigilant™ OraFusion System, the first and only technology that measures tumor-initiating and stem cell associated biomarkers – markers clinically validated to be associated with oral cancer – was developed to aid clinicians in the early detection of oral cancer. The point-of-care BeVigilant™ OraFusion System uses a simple collection method that is easy to administer and non-invasive for the patient. The test has the potential to benefit adults at risk of oral cancer, with particular emphasis on high-risk populations (i.e., current and former tobacco users, those who consume excessive alcohol, and people with human papillomavirus, HPV-16). The BeVigilant™ OraFusion System is CE Marked and available in select markets outside of the United States. The BeVigilant™ OraFusion System is not available for sale in the U.S. Leadership: Bill Brodie, Chief Executive Officer Robert T. Hamilton, CPA, Chief Financial Officer Dragan Nebrigic, Ph.D., Chief Operating Officer Ben Beckham, Chief Commercial Officer Michael Donovan, M.D. Ph.D., Chief Clinical Officer |
VolitionRx Austin, Texas, United States | We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics. Our mission is to save lives and improve outcomes for millions of people and animals worldwide. Imagine a world where diseases like cancer and sepsis can be diagnosed early and monitored easily using routine blood tests. That's the world we're trying to build by developing our innovative family of simple, easy to use, cost-effective tests. Our patented technologies use chromosomal structures such as nucleosomes and transcription factors as biomarkers in cancer and other diseases. All the tests in our portfolio detect various characteristic changes that occur from the earliest stages of disease, enabling early detection and potentially a better way to monitor disease progression and a patient's response to treatment. Our ground breaking nucleosome quantification technology is currently being used for cancer applications in veterinary medicine and we are continuing to expand our technology in human medicine through early clinical trials in cancer, sepsis and beyond. Regarding our Nu.Q® technology, we have four pillars of focus: Nu.Q® Vet, Nu.Q® NETs, Nu.Q® Discover and Nu.Q® Cancer. We have also developed Capture-PCR™, a novel method for liquid biopsy enabling rapid, cost-effective cancer detection in a routine blood test. We are headquartered in Henderson, Nevada with locations in Belgium, California, Singapore and the UK. We are listed on the New York Stock Exchange (NYSE AMERICAN) as VolitionRX Limited (VNRX). |